3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline

The amino group on this intermediate participates in a nucleophilic aromatic substitution or amide/urea-type coupling, forming a key bond that connects the imidazole-trifluoromethyl-substituted phenyl ring to the central scaffold of Nilotinib. The trifluoromethyl group and methyl-imidazole confer both lipophilicity and electronic effects, enhancing binding to the ATP-binding site of BCR-ABL while maintaining selectivity. In short, this intermediate is essential for introducing the hydrophobic and heterocyclic moieties that are critical for the drug’s potent kinase inhibition. 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline is an important intermediate in the synthesis of Nilotinib, functioning as the aryl amine component that couples with the previously constructed pyrimidine-pyridine-benzoic acid fragment.